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SUMMARY
For modern evidence-based medicine, a well thought-out risk scoring system for predicting
the timing of the occurrence of a clinical event plays an important role in selecting prevention and
treatment strategies. Such an index system is often established based on the subject’s “baseline”
genetic or clinical markers via a working parametric or semi-parametric model. To evaluate the
adequacy of such a system, C-statistics are routinely used in the medical literature to quantify the
capacity of the estimated risk score in discriminating among subjects with different event times.
When the event time is possibly censored, however, the commonly used C-statistics estimate
parameters which may depend on the study-specific censoring distribution. In this article, we
present a simple C-statistic without this shortcoming. The new procedure consistently estimates
a conventional concordance measure which is free of censoring. We provide a large sample
approximation to the distribution of this estimator for making inferences about this measure.
Numerical studies are also conducted to investigate the performance of the new procedure.
Keywords: AUC; Cox’s proportional hazards model; Framingham risk score; ROC.
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1. INTRODUCTION
For modern clinical medicine, risk prediction procedures are valuable tools for disease pre-
vention and management. Pioneered by the Framingham study, risk score systems have been
established for assessing individual risks of developing cardiovascular diseases (CVD), cancer or
many other conditions within a certain time period (Anderson et al., 1991; D’Agostino et al.,
2008; Shariat et al., 2008; Parikh et al., 2008). A key component in the assessment of risk algo-
rithm performance is its ability to distinguish subjects who will develop an event (“cases”) from
those who will not (“controls”). This concept, known as discrimination, has been well studied
and quantified using, for example, the estimated AUC, the area under the observed Receiver
Operating Characteristics (ROC) curve, which is also referred as a “C-statistic” (Bamber, 1975).
Such a statistic is an estimated conditional probability that for any pair of “case” and “control”,
the predicted risk of an event is higher for the “case” (Hanley & McNeil, 1982).
If the primary response variable is the time to a certain event, the aforementioned procedure
for binary outcomes can be used to quantify the ability of the risk score system to differentiate
cases from controls at a time point t. If one is not interested in a particular time point, a standard
concordance measure may be used to evaluate the overall performance of the risk scoring system.
Specifically, let T be the event time, Z be a p× 1 covariate vector, and g(Z) be the theoretical
counterpart of the estimated risk score for the subject with Z. Consider two independent copies
{(T1, Z1, g(Z1))′, (T2, Z2, g(Z2))′} of (T, Z, g(Z))′. A commonly used concordance measure is
C = pr(g(Z1) > g(Z2) | T2 > T1) (1.1)
(Heagerty & Zheng, 2005). When T is subject to right censoring, as discussed in Heagerty &
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Zheng (2005) one would typically consider a modified Cτ with a fixed, prespecified follow-up
period (0, τ), where
Cτ = pr(g(Z1) > g(Z2) | T2 > T1, T1 < τ). (1.2)
Estimation of (1.1) or (1.2) when the event time may be censored, however, is not straightforward
(Harrell et al., 1996; Pencina and D’Agostino, 2004; Gönen & Heller, 2005; Chambless & Diao,
2006).
The estimator for C or Cτ proposed by Heagerty & Zheng (2005) is derived under a propor-
tional hazards model. If this parametric working model is not correctly specified, the resulting
estimator may be biased. A popular nonparametric C-statistic for estimating C was proposed
by Harrell et al. (1996), which was extensively studied by Pencina & D’Agostino (2004). Note
that this generalization is a weighted average of the time-dependent AUCs, which corresponds
to the “incident/dynamic” ROC curve (Heagerty & Zheng, 2005; Cai et al., 2006) with weights
depending on the study-specific censoring distribution.
When the study individuals had differential follow-up times, the C-statistic studied by Harrell
et al. (1996) converges to an association measure, which depends on the study-specific censor-
ing distribution. In this article, under the general random censorship assumption, we provide
a simple, purely non-parametric estimator for (1.2), which is free of the censoring distribution.
Furthermore, we study the large sample properties of the new estimation procedure. Our pro-
posal is illustrated with two real examples. The performance of the new proposal under various
practical settings is also examined via a simulation study.
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2. INFERENCE PROCEDURES FOR DEGREE OF ASSOCIATION BETWEEN
EVENT TIMES AND ESTIMATED RISK SCORES
In this section, we consider a non-trivial case that at least one component of the covariate
vector Z is continuous. For the survival time T, let D be the corresponding censoring variable.
Assume that D is independent of T and Z. Also, let {(Ti, Zi, Di) , i = 1, . . . , n} be n independent
copies of {(T, Z,D)}. For the ith subject, we only observe (Xi, Zi,∆i) , where Xi = min (Ti, Di),
and ∆i equals 1 if Xi = Ti and 0 otherwise.
Suppose that we fit the data with a working parametric or semi-parametric regression model,
for example, a standard Cox proportional hazards model (Cox, 1972):
ΛZ(t) = Λ0(t) exp(β
′Z), (2.1)
where ΛZ(·) is the cumulative hazard function for subjects with covariate vector Z, Λ0(·) is the
unknown baseline cumulative hazard function and β is the unknown p× 1 parameter vector. Let
the maximum partial likelihood estimator for β be denoted by βˆ. Note that even when the model
(2.1) is not correctly specified, under a rather mild non-separable condition that there does not
exist vector ζ such that pr(T1 > T2 | ζ ′Z1 < ζ ′Z2) = 1, βˆ converges to a constant vector, say, β0,
as n→∞. This stability property is important for deriving the new inference procedure.
For a pair of future patients with covariate vectors {Z0k , k = 1, 2} and the potential survival
times {T 0k , k = 1, 2}, their corresponding risk scores are {βˆ′Z0k , k = 1, 2}. To evaluate this risk
score system, one may use the concordance measure discussed in Section 1:
Cn = pr(βˆ′Z01 > βˆ
′Z02 | T 01 < T 02 ),
4
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where the probability is evaluated with respect to the data, and (T 01 , Z01) and (T 02 , Z02). Note that
Cn depends on the sample size. Let the limit of Cn be denoted by
C = pr(β′0Z
0
1 > β
′
0Z
0
2 | T 01 < T 02 ). (2.2)
Now, since the support of the censoring variable D is usually shorter than that of the failure
time T, the tail part of the estimated survival function of T is rather unstable. Therefore, we
consider a truncated version of C in (2.2), that is,
Cτ = pr(β′0Z
0
1 > β
′
0Z
0
2 | T 01 < T 02 , T 01 < τ),
where τ is a prespecified time point such that pr(D > τ) > 0.
It follows from an “inverse probability weighting” technique proposed by Cheng et al. (1995)
for dealing with a completely different problem in survival analysis that Cτ can be consistently,
nonparametrically estimated by
Cˆτ =
∑n
i=1
∑n
j=1 ∆i{Gˆ(Xi)}−2I(Xi < Xj, Xi < τ)I(βˆZi > βˆZj)∑n
i=1
∑n
j=1 ∆i{Gˆ(Xi)}−2I(Xi < Xj, Xi < τ)
, (2.3)
where I(·) is the indicator function and Gˆ(·) is the Kaplan-Meier estimator for the censoring
distribution G(t) = pr(D > t). Heuristically, the consistency of the above estimator follows from
the fact that as n→∞, the denominator of (2.3) divided by n2 converges to
E
{
∆1I(X1 < X2, X1 < τ)
G2(X1)
}
= E
[
E
{
I(T1 < T2, T1 < τ)I(D1 ∧D2 > T1)
G2(T1)
∣∣∣∣T1}]
= pr(T1 < T2, T1 < τ),
and the numerator of (2.3) divided by n2 converges to pr(β′0Z01 > β′0Z02 , T 01 < T 02 , T 01 < τ).
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In the Appendix, we show that
W = n
1
2 (Cˆτ − Cτ )
is asymptotically normal with mean 0. Moreover, in the Appendix, we show how to use a
perturbation-resampling method to approximate the distribution ofW. Specifically, we show that
the asymptotic distribution of W˜ given in (5.2) is the same as that of W. The realizations of W˜
can be generated easily by simulating a large number, M, of random samples from, for instance,
the unit exponential. Inferences about Cτ can then be made via the normal approximation to the
distribution of Cˆτ and these realizations of W˜ . For instance, a two-sided 0.95 confidence interval
for Cτ would be Cˆτ ± 1.96n−1/2σ, where σ2 is the standard sample variance or a robust version
thereof based on the above M realizations of W˜ .
It is important to note that the C-statistic proposed by Harrell et al. (1996) is
∑
i6=j ∆iI(Xi < Xj)I(βˆZi > βˆZj)∑
i6=j ∆iI(Xi < Xj)
, (2.4)
which converges to a quantity which involves the study-specific censoring distribution:
pr(β0′Z01 > β0
′Z02 | T 01 < T 02 , T 01 ≤ D01).
Pencina & D’Agostino (2004) formulated C-statistic by allowing various τ. Their C-statistic is
∑
i6=j ∆iI(Xi < Xj, Xi < τ)I(βˆZi > βˆZj)∑
i6=j ∆iI(Xi < Xj, Xi < τ)
, (2.5)
which converges to
pr(β0′Z01 > β0
′Z02 | T 01 < T 02 , T 01 ≤ D01, T 01 < τ).
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3. NUMERICAL STUDIES
First, we illustrate the new estimation procedure with two data sets. The first one is from the
Framingham Heart Study. For this data set, there were 3087 study participants whose baseline
covariate vectors Z’s were obtained at their study entry times between 1991 and 1995. Here,
each Z consists of age, gender, smoking status (SMK), total cholesterol (TC), HDL cholesterol
(HCD), systolic blood pressure (SBP) and use of medication for high blood pressure (TxBP).
These individuals were then followed until Year 2006. Here, the event time T is the first time that
the subject had a cardiovascular disease event (coronary death, myocardial infarction, coronary
insufficiency, angina pectoris, fatal and non-fatal stroke, intermittent claudication or congestive
heart failure). For this data set, there are 377 such events observed during the entire follow-up
period, and 282 of which occurred in the first 10 years. The Kaplan-Meier estimates for the
survival distributions of the event time T and the censoring D are given in Figure 1. Note that
most study subjects were followed more than ten years, but less than 13 years.
We fitted the data with a Cox proportional hazards model (2.1). The resulting risk score
βˆ′Z0 is
0.54× (AGE/10)− 0.41× I(Male) + 0.53× I(SMK=Yes)
+0.40× (TC/102[mg/dL])− 0.21× (HDL/10[mg/dL])
+0.15× (SBP/10[mmHg]) + 0.33× I(TxBP=Yes).
In Table 1, for various τ, we present point estimates for our C-statistics and their corresponding
0.95 confidence intervals for Cτ . When τ = 8, 10, 12 (years), our results are very similar to those
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based on the conventional C-index (2.4) procedure with a point estimate of 0.75 and a 0.95
confidence interval of (0.73, 0.77). Note that all the τ -specific C-statistics (2.5) give us similar
point and interval estimates. When τ = 14, our estimated standard error for the new C-statistic
is markedly larger than that of the conventional method. For this case, study subjects did not
have similar follow-up times and it is known that the existing methods in the literature may
not work well (Pencina & D’Agostino, 2004). Note that all the results reported in Table 1 were
based on M = 500 independent realizations of a random sample with n = 3087 from the unit
exponential for (5.2).
The second data set for illustration is from a recent cancer study (Chang et al., 2005). This
study was designed to evaluate the prognostic value of a new gene signature constructed from
the patient’s microarray gene expression data to predict the time of the future patient’s death or
metastasis. The data set consists of 295 breast cancer patient records from the Netherlands Can-
cer Institute. The details of participants of the study are given in van’t Veer et al. (2002) and van
de Vijver et al. (2002). One of the clinical implications for establishing a risk score system is to
identify future patients who may benefit from adjuvant systemic, but potentially toxic, therapies.
For illustrating our proposal, we let T be the patient’s survival time. The Kaplan-Meier estimates
for the survival functions of the event and the censoring are given in Figure 2. Note that at Year
15, the survival rate is 0.61, the size of the risk set is 19, and there were no deaths beyond this
time point. The patient’s baseline covariates consist of the new gene score and other conventional
markers such as age, number of positive lymph-node, estrogen receptor status, diameter of tu-
mor, histologic grade, vascular invasion, chemotherapy, hormonal therapy, mastectomy or breast
8
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conserving surgery et al. (http://microarray-pubs.stanford.edu/wound_NKI/explore.html).
We first fitted the data with the clinical variables only via the standard stepwise procedure
with Cox’s proportional hazards model. The covariate vector Z for the final model consists of
age, estrogen receptor (ER: positive or negative) and tumor grade (GR: 1, 2, 3). The resulting
risk score βˆ′Z is
−0.42× (AGE/10)− 0.74× I(ER=positive) + 1.53× I(GR=2) + 2.01× I(GR=3).
In Table 2, with various τ, based on our C-statistic, we report the point estimates and the
corresponding 0.95 confidence intervals for Cτ . Our standard error estimates tend to be larger
than that from the conventional C-statistic. When τ = 15, our interval is much wider than the
conventional one by taking care of the unstable inverse weighting probability estimate Gˆ(·) at
the tail part of the curve. The conventional C-statistic gives a biased estimator for Cτ and its
interval estimator may not have the adequate coverage level.
Now, if we fit the data with a Cox model, which includes the gene score variable (GS) and
the above three conventional variables, the risk score is
2.43× (GS)− 0.56× (AGE/10)− 0.55× I(ER=positive) + 1.25× I(GR=2) + 1.52× I(GR=3).
We also report the results in Table 2, which are similar to those without using gene score.
To examine the performance of the new proposal, for example, the interval estimation proce-
dure, we conducted an extensive numerical study under various practical settings. To be specific,
we first created a true survival regression model to relate T to Z and also a censoring distribution
for D. For example, for one case in our study, we generated the model by fitting the above cancer
9
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data with a Weibull regression survival model that has four baseline covariates: age, estrogen
receptor status, tumor grade and gene score. We then fitted the data with a one-sample Weibull
distribution (with two unknown parameters) for the censoring distribution G(·). For this case,
the resulting censoring is heavy (about 70% censoring by Year 15). To simulate a data set sim-
ilar to the cancer data, the covariate vector Z with the aforementioned four components was
randomly generated from its empirical distribution based on the above observed gene-expression
cancer data. For each selected Z, we generated T via the above Weibull regression model and
also an independent censoring D from the one-sample Weibull. The resulting data point is
(X,∆, Z)′. With one million of such simulated data points, we obtain the “true” C15, which is
0.75. Next, to examine the adequacy of the coverage probabilities of our 0.95 confidence inter-
val estimator for C15, for a given sample size n, we generated 1000 independent realizations of
{(Xi,∆i, Zi)′, i = 1, · · · , n} under the above simulation setting. We then fitted each simulated
data set with a working Cox regression model (not necessarily the correct model) and obtained
estimated risk scores. With this scoring system, we constructed a 0.95 confidence interval for
C15 in (2.3). We repeated this process and obtained 1000 realized confidence intervals with the
nominal level of 0.95. With various working models and n = 300, the empirical coverage levels
of our interval estimators are around 0.97. With n = 500 and various working Cox’s models,
the empirical levels are about 0.95. We also considered a case when the censoring is relatively
light (about 60% censoring at Year 15) by multiplying the above censoring variable by 2.7, the
empirical coverage levels are from 0.94 to 0.95. Based on the results of the extensive simulation
study, we find that the new interval estimation procedure performs well, that is, the empirical
10
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coverage levels are practically identical to their nominal counterparts.
4. REMARKS
In this article, we show that an over-all performance of predicting the subject-level survival
over the entire interval (0, τ) based on a parametric or semi-parametric model can be evaluated
via a simple, unbiased estimation procedure for Cτ . Based on our extensive numerical study,
generally we find that the new estimation procedure is robust with respect to the choice of τ.
However, if the pre-specified τ is “too” large such that very few events were observed or very few
study subjects were followed beyond this time point, the standard error estimate for Cˆτ can be
quite large, reflecting a high degree of uncertainty of our inferences about Cτ . For this case, one
should cautiously utilize the fitted model for prediction over this large time interval.
There are various C-statistics proposed in the literature. With the same technique utilized
in this article, one may modify these statistics accordingly so that they estimate concordance
measures which are free of the study-specific censoring distribution. The computer code for imple-
menting the new inference procedure can be downloaded from (http://bcb.dfci.harvard.edu/˜huno).
When the dimension of the covariate vector Z is greater than one, the estimated risk scoring
system may not perform well based on a purely nonparametric function estimation procedure.
A feasible alternative is to construct a risk index system via a parametric or semi-parametric
model as we did in this article. One may then use this scoring system to group future subjects,
but calibrate the corresponding stratum-specific risk estimates via a univariate nonparametric
function estimation procedure (Cai et al., 2009). In any event, to obtain an efficient and reliable
final product, it is crucial to examine the adequacy of the parametric risk index system. Recently
11
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alternative quantification methods other than using C-statistics for evaluating the performance
of risk prediction procedures have been proposed (Pencina et al., 2008; Cai et al., 2008). Further
research along this line is warranted.
5. APPENDIX: LARGE SAMPLE PROPERTIES OF Cˆτ
Throughout, we assume that the non-separable condition for (T, Z) given in section 2 holds
and thus β0 is the unique solution to the limiting of the following partial likelihood score equation,
U(β) = n−1
n∑
i=1
Ui(β) = n
−1
n∑
i=1
∫ τ
0
{
Zi −
∑
j Yj(t) exp(β
′Zj)Zj∑
j Yj(t) exp(β
′Zj)
}
dNi(t) = 0,
where Ni(t) = I(Xi ≤ t,∆i = 1), Yi(t) = I(Xi ≥ t). We assume that β0 lies in a compact param-
eter space and the joint density of (T, Z) is continuous and bounded. To show the consistency
of Cˆτ , we first note that
n1/2(βˆ − β0) = n−1/2
n∑
i=1
A(β0)Ui(β0) +Op(n
−1) (5.1)
where A(β) = −{∂E(U(β))/∂β}−1 (Hjort, 1992).
Now, for a fixed β, let
Cτ (β) = pr(β′Z01 > β
′Z02 | T 01 < T 02 , T 01 < τ).
It follows from the uniform consistency of Gˆ(·), the convergence of βˆ to β0, and a uniform law of
large numbers for U -processes (Nolan & Pollard, 1987), that Cˆτ converges to Cτ (β0) in probability
as n→∞. On the other hand, it follows from the asymptotic expansion of βˆ given in (5.1) that
Cτ (β0)− Cτ = O(n−1). Thus, Cˆτ − Cτ → 0 in probability.
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To approximate the distribution of
W = n
1
2
{
Cˆτ (βˆ)− Cτ
}
,
we first obtain asymptotic expansions for W (β) = n1/2{Cˆτ (β)−Cτ (β)}, where Cˆτ (β) is obtained
by replacing βˆ in Cˆτ of (2.3) with β. To this end, we write W (β) = Wa(β) +Wb(β), where
Wa(β) = n
1/2
∑n
i=1
∑n
j=1 Iij(τ)G(Xi)
−2{I(β′Zi > β′Zj)− Cτ (β)}∑n
i=1
∑n
j=1 Gˆ(Xi)
−2Iij(τ)
,
Wb(β) = n
1/2
∑n
i=1
∑n
j=1{Gˆ(Xi)−2 −G(Xi)−2}Iij(τ){I(β′Zi > β′Zj)− Cτ (β)}∑n
i=1
∑n
j=1 Gˆ(Xi)
−2Iij(τ)
and Iij(τ) = I(Xi < Xj, Xi < τ)∆i. Now, it follows from the standard asymptotic theory for the
Kaplan Meier estimator (Kalbfleish & Prentice, 2002),
WˆG(t) =
n1/2{G(t)− Gˆ(t)}
G(t)
≈ n−1/2
n∑
i=1
ψi(t)
and WˆG(t) converges weakly to a zero-mean Gaussian process indexed by t for t ≤ τ , where
ψi(t) =
∫ t
0
dMi(u)/piX(u), piX(t) = pr(Xi ≥ t) and Mi(t) = I(Xi ≤ t,∆i = 0) −
∫ t
0
I(Xi ≥
u)dΛD(u), ΛD(·) is the cumulative hazard function for the common censoring variable. Also,
it follows from the uniform consistency of Gˆ(·) and a functional central limit theorem for U -
processes (Nolan & Pollard, 1988) that
Wa(β) = n
−3/2p(τ)−1
n∑
i=1
n∑
j=1
G(Xi)
−2Iij(τ){I(β′Zi > β′Zj)− Cτ (β)}+ op(1),
where p(τ) = P (T1 < T2, T1 < τ). Furthermore,
Wb(β) =
∫ τ
0
n1/2
{
G(t)2
Gˆ(t)2
− 1
}
dγˆ(t, β)
13
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where
γˆ(t, β) =
∑n
i=1
∑n
j=1G(Xi)
−2I(Xi ≤ t)Iij(τ){I(β′Zi > β′Zj)− Cτ (β)}∑n
i=1
∑n
j=1 Gˆ(Xi)
−2Iij(τ)
.
By a uniform law of large numbers for U -processes (Nolan & Pollard, 1987) and the uniform
consistency of Gˆ(·), we have
sup
t∈[0,τ ],β
|γˆ(t, β)− γ(t, β)| → 0, in probability
where
γ(t, β) =
p(t) {pr(β′Zi > β′Zj | Ti < Tj, Ti < t)− Cτ (β)}
p(τ)
.
This, coupled with the weak convergence of WˆG(t), implies that
Wb(β) = 2
∫
WˆG(t)dγ(t, β) + op(1) = n
−1/2
n∑
i=1
2
∫
ψi(t)dγ(t, β).
Therefore,
W (β) =
(
n
2
)−1∑
i<j
{Vij(β) + φij(β)}+ op(1),
where Vij(β) = (Vij(β) + Vji(β))/2,
Vij(β) = p(τ)
−1G(Xi)−2Iij(τ){I(β′Zi > β′Zj)− Cτ (β)},
and φij(β) =
∫ {ψi(t) + ψj(t)} dγ(t, β). It then follows from a functional central limit theorem
for U -processes that W (β) converges weakly to a zero-mean Gaussian process. This, together
with the continuity of Cτ (β) and the asymptotic expansion of n1/2(βˆ − β0), implies that
W = W (β0) + C˙τ (β0)n
1/2(βˆ − β0) + op(1) =
(
n
2
)−1∑
i<j
Wij + op(1),
14
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where C˙τ (β) = ∂Cτ (β)/∂β and
Wij = Vij(β0) + φij(β0) + C˙τ (β0)A(β0){Ui(β0) + Uj(β0)}/2.
This, together with the standard asymptotic theory of U -statistics, W is asymptotically normal
with mean 0 and variance E(W12W13).
To estimate the variance of W, we utilize a perturbation-resampling method which has been
successfully used for handling numerous inference problems in survival analysis (Lin et al., 1993;
Lin et al., 1994). To be specific, let {Ξi, i = 1, . . . n} be a sets of n iid random variable from a
known distribution with mean 1 and variance 1. For large n, we can approximate W with the
conditional distribution (conditional on the data) of
W˜ =
(
n
2
)−1∑
i<j
Vˆij(βˆ)ΞiΞj + n1/2{Kˆ(G∗)− Kˆ(Gˆ)}+ n1/2{Cˆτ (β∗)− Cˆτ (βˆ)}, (5.2)
where
Kˆ(G) = pˆ(τ)−1
(
n
2
)−1∑
i<j
G(Xi)
−2Iij(τ){I(βˆ′Zi > βˆ′Zj)− Cˆτ (βˆ)},
pˆ(τ) = n−2
∑n
i=1
∑n
j=1 Gˆ(Xi)
−2Iij(τ), and G∗(·) and β∗ are the corresponding perturbed version
of Gˆ(·) and βˆ. Specifically, G∗(t) is generated by
G∗(t) = Gˆ(t)− Gˆ(t)
(
n
2
)−1∑
i<j
∫ t
0
pˆi−1X (u)
{
dMˆi(u) + dMˆj(u)
}
ΞiΞj/2
where pˆiX(u) = n−1
∑n
i=1 I(Xi ≥ u), Mˆi(t) = I(Xi ≤ t,∆i = 0) −
∫ t
0
I(Xi ≥ u)dΛˆD(u) and
ΛˆD(·) is a consistent estimator of the cumulative hazard function for the censoring variable. We
generate β∗ as
β∗ = βˆ +
(
n
2
)−1∑
i<j
[
Aˆ(βˆ){Ui(βˆ) + Uj(βˆ)}/2
]
ΞiΞj.
15
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Note that only the random quantity in W˜ is {Ξi, i = 1, . . . , n}. The unknown quantities are
replaced with their empirical counterparts. The distribution of W˜ (and therefore the distribution
of W ) can be approximated by generating a large number of realized random samples from
{Ξi, i = 1, . . . n} .
16
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Table 1. Point estimates (Est), standard error estimates (SE) and 0.95 confidence intervals
(CI) for Cτ with Framingham study Data
C-index New Method Conventional
τ Est SE CI Est SE CI
8 0.76 0.02 (0.73, 0.79) 0.76 0.01 (0.73, 0.79)
10 0.75 0.01 (0.72, 0.78) 0.75 0.01 (0.73, 0.78)
12 0.75 0.01 (0.72, 0.77) 0.75 0.01 (0.73, 0.78)
14 0.75 0.02 (0.70, 0.80) 0.75 0.01 (0.73, 0.78)
∞ NA NA NA 0.75 0.01 (0.73, 0.77)
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Table 2. Point estimates (Est), standard error estimates (SE) and 0.95 confidence intervals
(CI) for Cτ with breast cancer data
C-index New Method Conventional
τ Est SE CI Est SE CI
Without Gene Score Model
6 0.75 0.04 (0.68, 0.82) 0.76 0.03 (0.70, 0.82)
8 0.74 0.03 (0.67, 0.81) 0.76 0.03 (0.70, 0.81)
10 0.74 0.03 (0.68, 0.81) 0.75 0.03 (0.70, 0.81)
15 0.68 0.05 (0.58, 0.78) 0.75 0.03 (0.70, 0.81)
∞ NA NA NA 0.75 0.03 (0.70, 0.81)
With Gene Score Model
6 0.77 0.03 (0.71, 0.84) 0.78 0.03 (0.72, 0.83)
8 0.77 0.03 (0.71, 0.83) 0.78 0.03 (0.72, 0.83)
10 0.77 0.03 (0.71, 0.83) 0.77 0.03 (0.72, 0.82)
15 0.71 0.05 (0.61, 0.81) 0.77 0.03 (0.72, 0.82)
∞ NA NA NA 0.77 0.03 (0.72, 0.82)
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Figure 1. Estimates for survival functions for CV events and censoring variables with Framing-
ham study data.
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Figure 2. Estimates for survival functions for CV events and censoring variables with breast
cancer data.
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